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Objectives: (1) To determine the proportio~ of patients with critical imb ischaemia refractory to invasive treatment that 
can be successfully treated by dorsal column stimulation (DCS), and (2) to identify potential responders toDCS by a 
simple test that is sufficiently predictive to limit the need for a prolonged trial stimulation period. 
Patients and methods: Twenty patients with chronic limb-threatening schaemia were assessed by a battery of macro- 
and microcirculatory tests and a DCS trial of i week. Favourable r sponse during the trial determined selection for long- 
term stimulation. 
Results: During a mean observation period of 14 months, limb salvage rate (LSR) was 63% overall and 83% among 
patients elected after a favourable trial. Of the tests performed preoperatively, digital subtraction angiography, Doppler 
assessment, oscillometry, capillaroscopy, foot temperature, and transcutaneous partial pressure of oxygen (tcp02) in the 
supine or sitting position did not adequately predict DCS response. The supine-sitting tcp02 gradient (dtcp02) was a 
good predictor of DCS outcome, with an 88% LSR when 3tcp02 >15 Torr, dropping to 12% when 3tcp02 <_ 15 Torr. 
Conclusions: DCS is a rewarding therapeutic option in selected patients with critical imb ischaemia. Atcp02 appears 
to reliably predict response to DCS and may obviate trial stimulation i  most cases. 
Key Words: Dorsal column stimulation; Unreconstructible limb ischaemia; Identification ofpotential responders. 
Introduction 
In patients with severe and otherwise untreatable peri- 
pheral artery occlusive disease (PAOD), dorsal column 
stimulation (DCS) has limb-saving potential, 1-8 an effect 
attributed to modulation of neuropathic pain 3'9'1° 
and to significant modification of microcirculatory 
function. ~-ls Nevertheless, the technique has not 
gained widespread acceptance, s6 in part because it is 
costly and poorly understood. ~7-2° Demonstration of its 
clinical effect is based on complex and time-consuming 
microcircutatory tests whose limited predictive value 
has until now precluded their use for screening pur- 
poses. Selection of candidates for DCS is thus a difficult 
task currently accomplished by means of a trial stimu- 
lation which may last days to weeks and is onerous 
in terms of patient discomfort and public health ex- 
penditure. This study was designed (1) to assess the 
response to DCS in 20 consecutive patients with limb- 
threatening ischaemia and (2) to establish a simple 
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and less time- and resource-consuming test that is 
sufficiently predictive of DCS outcome to offset, or at 
least to limit, the need for trial stimulation. 
Materials and Methods 
Between June 1991 and October 1994, 20 patients (16 
males) aged 37 to 89 years (mean and median 70 years) 
with severe refractory ischaemic disease of one (n = 
16) or both (n =4) lower limbs were enrolled for DCS 
treatment. Of 24 lower limbs treated, six (25%) had 
intractable rest pain and 18 (75%) rest pain associated 
with ischaemic leg ulcers. Arterial insufficiency had 
developed as a result of atherosclerosis in 21 limbs, 
thromboangiitis obliterans in two, and a neglected 
post-traumatic arterial thrombosis in one. 
The ankle pressure was not measurable in seven 
limbs owing to severe arterial calcification. Ankle- 
brachial pressure indices (ABI) were less than 0.35 in 
12 others, while in the remaining five limbs ABI was 
greater than 0.35 but associated with significant soft- 
tissue lesions of the distal foot and with absence of 
both measurable pressure and pulsatile Doppler flow 
at the toe level. 
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Table 1. Patient characteristics and DCS outcome. 
n % Response Non- 
(24) response 
Diabetes mellitus 5 21 2 3 
Hypertension 6 25 3 3 
Smoking 11 46 6 5 
Prior heart surgery 7 29 4 3 
Congestive heart failure 7 29 4 3 
Atrial fibrillation 3 12 2 1 
Stroke or TIA 4 17 3 1 
Controlateral amputation 2 8 1 1 
Table 2. Arterial disease prior treatment and DCS outcome° 
n % Response Non- 
(24) (%) response 
(%) 
Stage III PAOD 6 25 4 (67) 2 (33) 
Stage IV PAOD 18 75 11 (61) 7 (39) 
Atherosclerosis 21 88 12 (57) 9 (43) 
With trash-foot 2 8 2 0 
With blue-toe 2 8 2 0 
Thromboangiitis obliterans 2 8 2 0 
Trauma 1 4 1 0 
Prior sympathectomy 10 42 6 (60) 4 (40) 
Prior prostaglandin 4 17 3 (75) 1 (25) 
Previous treatment regimens included repeated ar- 
terial surgery (mean, 2.1 procedures per patient), 
lumbar sympathectomy in 10 cases and intravenous 
prostaglandin four (Ilomedin®, Schering AG; Pro- 
stavasin®, Schwarz Pharma AG). Baseline data are 
provided in Tables 1 and 2. 
Suitability for DCS was determined in accordance 
with generally accepted criteria, 3'4'7-9 i.e. ischaemic limb 
disease that was: (a) inaccessible to surgery or an- 
gioplasty; (b) chronic, meaning clinically stable for at 
least 3 weeks preceding enrolment; (c) characterised 
by intractable rest pain; and (d) not associated with 
skin ulceration exceeding 3 cm 2. Criteria leading to 
exclusion were: (a) poor patient compliance (frequently 
encountered in patients with advanced PAOD); (b) 
peripheral nerve disease likely to substantially modify 
pain perception; and (c) major deformation or stenosis 
of the thoracolumbar spine. 
The study involved five phases: 
I1. Preoperative work-upl 
; 
[2. Electrode implantation] 
13. Trial stimulation I~  lAb. Removal] 
[ 4a. Stimulator internalisation ] 
} 5. Serial postoperative evaluation I
Phases 2, 4a and 4b were surgical procedures per- 
formed in the operating room. Phase 3 was carried 
out at the hospital. 
Phases 1 and 5 were performed either during hos- 
pitalisation or in the outpatient clinic. 
Preoperative work-up 
This included: 
Assessment by a qualified vascular surgeon and an 
interventional ngiologist to rule out surgical and/  
or angioplasty treatment options, including pedal 
arch bypass. 
Clinical examination of each patient, followed by 
an interview to ascertain probable patient com- 
pliance and to obtain informed consent for DCS 
treatment. 
Evaluation of the macrocirculation by intra-arterial 
digital subtraction angiography, by ankle systolic 
pressure measurements over the posterior tibial and 
dorsal pedal artery with a continuous wave Doppler 
device, and by oscillography. Toe pressure was 
measured by the reappearance of a laser Doppler 
flux signal after deflation of a minicuff connected 
to a pressure unit. Evaluation of the microcirculation 
by determination of distal foot skin temperature 
(Technoterm 9500, Quarz AG, MOnchaltdorf, Swit- 
zerland), and of the transcutaneous partial pressure 
of oxygen (tcpO2) in the sitting and supine positions 
at 45°C (Cutan pO2 Monitor 820, Kontron Medical, 
Zfirich, Switzerland). These measurements were 
routinely performed on the dorsum of both feet as 
distally as possible in the first interosseous space, 
whereas quantitative capillaroscopy was performed 
(when possible) in the sitting position at proximal 
and distal segments of the first toe, as described 
elsewhere. 21-23 The capillary density was determined 
in the sitting position at magnification 4 x, and 
expressed as the number of capillary loops per mm 2. 
Sural nerve neuronography to detect peripheral 
neuropathies not revealed by clinical examination. 
When necessary, imaging studies of the thoraco- 
lumbar spine. 
Operative technique 
After instillation of local anaesthetic (Scandica/n®, 
Astra Pharm AG), a small L1 laminectomy (or, in 
suitable cases of unilateral ischaemic disease, an in- 
terlaminar fenestration) was performed and a quadri- 
polar electrode (Resume, Medtronic Inc, Minneapolis, 
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Fig. 1. Variation in tcpO2 recorded uring 12 weeks of DCS. (O) healthy leg, dependent; ([~) ischaemic leg, dependent; (Q) healthy leg, 
supine; (11) ischaemic leg, supine. 
MN, U.S.A.) introduced in the epidural space and 
guided to the T10-11 level under fluoroscopic ontrol. 
In the presence of bilateral ischaemia, the electrode 
was placed centrally, the paramedian position being 
used for unilateral ischaemic disease. Direct stimu- 
lation inducing "pleasant" paresthesias in the entire 
painful zone of the ischaemic limb indicated correct 
positioning of the electrode, which was then fixed to 
the dura and to the thoracolumbar fascia by Prolene® 
stitches and connected to a percutaneous extension 
cable linked to a portable xternal stimulating device. 
Postoperative evaluation 
With the exception of angiography, neuronography 
and imaging studies of the thoracolumbar spine, in- 
vestigations performed preoperatively were repeated 
after 5 days of trial stimulation, and patients responsive 
to trial DCS were reassessed 1, 2, 6 and 12 weeks 
after internalisation. An identical work-up was also 
undertaken in the presence of any significant un- 
expected modification of the clinical status. 
Trial stimulation phase 
Response to DCS was evaluated by continuous timu- 
lation (frequency 80-180 Hz, pulse length 180-270 gs, 
intensity 0.2-4V) for 1 week. Complete pain relief 
along with an increase in tcpO2 >_ 15% of the base 
value (making a trivial placebo effect unlikely) at 
the end of the trial week were considered a suitable 
indication for long-term DCS, whereupon the stim- 
ulator was internalised, a procedure performed in most 
cases during a brief general anaesthetic. Persistence of 
rest pain led to DCS cessation and removal of the 
spinal electrode. Two cases with equivocal results were 
given a second week of trial stimulation and were re- 
evaluated on the basis of the pain status and of two 
further microcirculatory studies performed at days 10 
and 14. 
Statistical analysis 
Data are presented as mean values ± S.D. Differences 
were assessed by the Student's t-test for parametric 
variables and by the Wilcoxon test for non-parametric 
variables, both for a bidirectional hypothesis. A null- 
hypothesis probability of less than 0.05 was considered 
significant. 
Results 
At the latest postoperative follow-up (range 8-25, 
mean 14 months), limb salvage rate (LSR) was 63% 
(15 of 24 lower limbs in 20 patients at risk). Treatment 
was unsuccessful in nine limbs, i.e. during the trial 
stimulation period in six limbs and 1-6 weeks after 
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(a) (b) (c) 
Fig. 2. Oscillograms of a patient with a 5 month history of bilateral blue toe syndrome who developed necrosis in three digits of the 
left foot and all digits of the right foot: (a) 3 months prior to DCS, (b) immediately prior to DCS, (c) after 10 days of DCS. With DCS, 
tcpO2 recorded on the dorsum of the non-dependent foot rose from 28 to 50 Tort on the right and from 42 to 59 on the left; rest pain 
disappeared and all necrotic lesions healed in 5 weeks. 
stimulator internal±sat±on in three. Thus after device 
internal±sat±on LSR was 83% (15 of 18 limbs) and 
procedure success rate was 79% (11 of 14 patients). 
DCS results were less favourable in patients with 
diabetes mellitus (LSR 40%) and/or arterial hyper- 
tension (LSR 50%), whereas prior sympathectomy 
and/or prostaglandin fusion did not adversely affect 
outcome (Tables 1 and 2). Non-response to DCS was 
followed by amputation in eight cases (four below- 
knee, one transgenicular, three above-knee). In one 
case it was possible to surgically locate a segment of 
vessel in the foot, and perform a successful pedal-arch 
bypass. 
Responders to DCS exhibited considerable func- 
tional improvement. In all 15 responding limbs isch- 
aemic rest pain was eliminated and opioid analgesic 
use discontinued. Walking perimeter was increased, 
with six patients in functional class II A and five in II 
B. Clinical improvement was correlated with ameli- 
oration of microcirculatory function, as evidenced by 
significant increases, at 3 months, in tcpO2 (mean, 
+ 120%, p<0.001), and capillary density (mean, +38% 
and + 40% respectively at the proximal and distal 1st 
toe, p<0.001) (Fig. 1). In cases where the electrode was 
placed in a paramedian position, greater micro- 
circulatory change was observed ipsilaterally. In sev- 
Table 3. DCS preoperative microcirculatory results. 
Parameter Responders Non-responders Altogether 
Mean S.D. ]9 valuer Mean s.n. Mean s.n. 
tcpO2 supine (Torrs) 19.5 + 15.1 <0.05 7 ± 11.2 15 ± 13.6 
tcpO2 dependent (Torrs) 42.2 ± 14.9 <0.01 17 + 18.2 33.2 ± 15.8 
AtcpO2 (Torrs) 23 ± 6.3 <0.01 11 + 16.4 18.6 ± 10.7 
Capillaroscopy* (basis) 29.2 +10.8 NS 23.7 + 8.7 27 ± 9.9 
Capillaroscopy* (tip) 31.2 ± 16.3 NS 30.6 + 15 31 ± 13.7 
Temperature (skin, °C) 30.4 ± 2.02 NS 29.4 ± 2.1 30.0 ± 2.0 
t-Two-tailed t-test for unrelated samples. 
* Number of perfused capillaries respectively at the basis and the tip of the first toe (pro field). 
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Fig. 3. Capillary density before DCS among responders (@) and 
non-responders (A), indicating correlation with outcome that was 
not significant. 
eral cases, a major increase in pulse amplitude was 
recorded in the toes (Fig. 2). 
As expected, response to DCS was highest in patients 
with capillary density in the upper range, but low 
capillary density did not preclude a favourable 
outcome (Fig. 3) and overall predictive value of this 
Table 4. Supine-sitting tcpO2 gradient and DCS outcome. 
AtcpO2 Response Non-response 
(Torr) (n = 15) (n = 9) 
0 0 3 
1-5 0 2 
6-10 0 1 
11-15 1 1 
16-20 4 1 
21-25 4 0 
26-30 2 0 
31-35 3 0 
36-40 1 0 
>40 0 1 
test was limited. Static tcpO2 determinations were also 
insufficiently reliable: 10/12 limbs (83%) with supine 
tcpO2 >15 Torr wer e salvaged, yet DCS was also suc- 
cessful in 5/12 limbs with tcpO2 <_ 15 Torr (42% = false 
negative rate), p = NS; similarly, a sitting tcpO2 value 
<20 Tort accurately predicted an unfavourable out- 
come since all limbs were amputated, but test speci- 
ficity was poor (56%) since of nine limbs not 
responding to DCS, four had an initial tcpO2 >20 Torr. 
A more reliable measure of DCS outcome was the 
sitting-supine tcpO2 gradient (AtcpO2), since 14/16 
limbs (88%) with AtcpO2 >15 Torr responded to DCS 
(Table 4), while a successful outcome was obtained in 
only 1/8 limbs (12%) with AtcpO2 < 15 Torr (p<0.01); 
sensitivity of this test was 93% and overall accuracy 
88%. Validity of tcpO2-based tests is summarised in 
Table 5. 
Cutaneous temperature (To) measurement was a 
poor predictor of DCS outcome, since responders and 
non-responders had almost identical values (mean Tc 
30.4 + 2.02°C and 29.4 + 2.1°C, respectively, NS). 
Discussion 
Patients in this study were selected after failure of 
previous therapeutic regimens. All subjects presented 
with severe ischaemic pain and were facing am- 
putation, as evidenced by the amputation rate in DCS 
non-responders (eight of nine limbs). One year LSR 
for all patients enrolled was 63% and 83% among 
patients who received long-term DCS, results that are 
comparable with femoro-infrapopliteal bypass graft- 
ing 24 and with advanced angioplastyY Unlike these 
techniques, however, DCS does not involve direct 
manipulation of vascular structures, and unsuccessful 
treatment will not negatively influence the extent of 
ischaemia or the level of amputation. Treatment with 
prostaglandin is controversial, and a recent study 26 
from our institution conducted on 14 similar patients 
yielded a i year LSR of only 28%. Of the four patients 
referred to us after unsuccessful prostaglandin in- 
fusion, successful DCS with limb salvage was obtained 
in three. 
Mechanism(s) underlying DCS action have not been 
Table 5. Validity of tcpO2 determination in screening patients for DCS treatment. 
Positive test Sensibility Specificity Positive predictive Negative predictive Overall 
Torr (%) (%) value value accuracy 
(%) (%) (%) 
Supine tcpO2 >15 66 78 83 
Sitting tcpO2 >20 100 56 79 
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unequivocally delineated. 17-2°'27 Changes in pain per- 
ception and vasomodulation via the autonomic nerv- 
ous system have been suggested. We observed a 
favourable response to DCS in 60% of patients with 
prior sympathectomy, which does not challenge the 
hypothesis of DCS-mediated modification of sym- 
pathetic tone since the latter is rarely wholly abolished 
by surgical or chemical ablation. Moreover, total 
sympathetic denervation i animals prevents a vaso- 
dilatory response to DCS. TM Poor correlation of macro- 
vascular assessments, such as ABI, with the severity 
of PAOD and with pain intensity suggest hat patho- 
logical microvascular alteration is a significant de- 
terminant of critical limb ischaemia. 28'29 Severe limb 
ischaemia is characterised by microcirculatory dys- 
regulation with abnormal vasoreactivity, uneven 
distribution of blood flow, interstitial oedema, com- 
pounded with platelet and leukocyte activation, micro- 
thrombosis and finally irreversible tissue damage. 5'29 
The beneficial effect of DCS on these microcirculatory 
changes has been demonstrated by thermography, 3'4 
vital microscopy, 8'11~3° laser Doppler flowmetry, 12,31,32 
measurement of tcpO2,2,13,15,33-35 and isotope clear- 
ance techniques. 1534-37 TcpO2 determination is often 
considered as the most easily and accurately re- 
producible test ~3'33-35 to demonstrate he effect of DCS 
on the microcirculation. This was confirmed with our 
first cases, so that the test was used throughout the 
study to exclude, before internalisation, those patients 
presenting with subjective improvement possibly due 
to a placebo effect. Suitability for permanent DCS is 
generally decided on the basis of improved results in 
one or more of these tests performed uring a trial 
stimulation period which is time- and resource-con- 
suming. Our results indicate that screening may be 
simplified, namely by supplanting trial stimulation 
with a single preoperative microcirculatory de- 
termination, the sitting-supine tcpO2 gradient (AtcpO2) 
which is a good assessment of remaining circulatory 
reserve and is demonstrably a reliable predictor of 
DCS outcome. We observed that a favourable DCS 
outcome occurred only when preoperative AtcpO2 
>15 Torr and sitting tcpO2 >20 Torr, regardless of su- 
pine tcpO2 values. A sitting tcpO2 of 20 Torr has also 
been suggested as the minimum for adequate post- 
amputation stump healing. 38 
Capillaroscopy performed at several different limb 
levels (mapping technique) may have a higher pre- 
dictive value than a single determination. Never- 
theless, the goal of this study being to investigate a 
relatively simple and inexpensive predictive test that 
could be performed by non-specialists, the mapping 
technique was deliberately not evaluated. Dynamic 
capillaroscopy with determination f red-cell velocity 
and afferent parameters was not assessed for the same 
reasons. AtcpO2 is a simple assessment, not requiring 
sophisticated equipment or trained personnel. Since 
the parameter is a difference of two values and not 
an absolute value, changes in AtcpO2 are unlikely 
to reflect inconsistency due to modification of blood 
oxygenation by variability in cardiac or pulmonary 
function. Serial tcpO2 determinations in the supine 
position showed arapid increase over the first 2 weeks 
of DCS followed by a levelling-off, with sitting tcpO2 
being approached after approximately 1 month of 
stimulation (Fig. 1). Thus, the benefit in tissue per- 
fusion and oxygenation due to increased hydrostatic 
pressure in the dependent asopposed to the recumbent 
leg is achieved after 1 month of DCS, albeit without 
the interstitial oedema nd rebound limb-threatening 
ischaemia commonly encountered after prolonged e- 
pendency. 39-41 In spite of these encouraging findings, 
long-term prognosis in DCS responders i  conditioned 
by irreversible arteriosclerotic progression which di- 
minishes the vascular eactivity that is probably in- 
strumental to DCS action, and may eventually lead 
to later treatment failure. Thus, during 6-48 month 
periods of stimulation, Horsch and Claeys 2observed 
an amputation rate of 3.5% per year. Nevertheless, 
given the advanced age and poor general condition 
of these patients as a whole, such results are clearly 
acceptable. 
In contrast to the traditional percutaneous method 
of epidural electrode implantation, 2'4'7'8'13'34'35 we 
approached the epidural space via a lumbar micro- 
laminectomy (or interlaminar fenestration), a tech- 
nique that is slightly more aggressive but possibly 
safer, since we did not encounter any of the com- 
plications uch as wound infection, electrode rupture 
or dislocation that occur in 30-50% of patients with 
percutaneously placed devices. 35'42-~4 Microlamin- 
ectomy performed under local anaesthesia s a well 
tolerated procedure which can be undertaken in 
patients in whom longer operations such as re- 
vascularisation r amputation might be hazardous. 
In conclusion, in selected patients with chronic stage 
III or IV ischaemic limb disease refractory to other 
modes of revascularisation, DCS is an effective thera- 
peutic option providing substantial symptomatic relief 
and a I year limb salvage rate of over 60%. Functional 
improvement, asmeasured by walking perimeter in- 
crease, is significant. These results are superior to 
those obtained with sympathectomy or prostaglandin 
infusion, and are comparable tothose of femoro-infra- 
popliteal bypass grafting. Unlike surgery, unsuccessful 
DCS does not involve the risk of ischaemic-zone ex- 
tension, nor are additional wounds created in poorly 
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oxygenated tissues with diminished healing capacity. 
Epidural electrode implantation via lumbar micro- 
laminectomy is a safe and relatively simple procedure, 
which in our experience averts most complications 
observed with the percutaneous method. Screening by 
AtcpO2 determination is simple and accurately predicts 
the remaining circulatory reserve likely to be exploited 
by DCS. Our results indicate that a AtcpO2 >20 Torr 
may be an indication for permanent DCS without rial 
stimulation, and that conversely a ditcpO2 < 15 Torr 
would contraindicate DCS treatment. With AtcpO2 
values in the 15-20Torr range, a trial stimulation 
period may still be warranted. A prospective trial 
involving a larger group of patients is needed to 
substantiate hese findings. 
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